Adrian James of Omada Health is coming to Diabetes Innovation

Adrian JamesWho are you? Where are you from? Why are you here?

I’m Adrian James, one of the co-founders of Omada Health. My background is mechanical engineering and design (10 years at IDEO), and my passion is inspiring better health and helping people stay away from preventable chronic disease.

Please tell us a little more about why you are interested in diabetes, professionally and/or personally.

I have type 2 diabetes in my family history and plenty of personal motivation to take health seriously, but the reasons I’m in this space have more to do with the desire to improve our food culture, address poor nutritional literacy, and raise awareness of prediabetes and the healthy path away from type 2. Additionally, at IDEO I spent years designing devices for people with type 1 and I feel very connected to the reality of managing blood sugar on a daily basis. [Read more...]

Bookmark and Share

Meet Stephen Phinney

Who are you? Where are you from? Why are you here?

Stephen Phinney MD (Internal Medicine), PhD (Nutritional Biochemistry)
Wondering that myself!

Please tell us a little more about why you are interested in diabetes, professionally and/or personally.

Specific interest in type-2 diabetes (T2DM), for which standard-of-care pharmaceuticals often do more harm than good.  [Read more...]

Bookmark and Share

Meet Barbara Haydon

Who are you? Where are you from? Why are you here?

Barbara Haydon, Provant Health Solutions.

We provide corporate health and wellness programs – diabetes is a major disease/chronic condition for which we provide screening, coaching and education.

Please tell us a little more about why you are interested in diabetes, professionally and/or personally.

I worked on an NIH diabetes grant for 10 years – have always been interested in protocols and treatment – both inpatient and outpatient. [Read more...]

Bookmark and Share

Look Who’s Coming: Robin Wagner

Who are you? Where areRobinWagner you from?

Robin S. Wagner, DVM, PhD
Director, Diabetes Management Solutions
Medical and Scientific Affairs, Diabetes Care

Roche Diagnostics Operations, Inc.
9115 Hague Rd, Building H
Indianapolis, IN, 46256
Phone: 317-521-2503
robin.wagner @ roche.com

Please tell us a little more about why you are interested in diabetes, professionally and/or personally.

Professional and personal interest. Diagnosed with type 2 in 1999. I am a pumper. [Read more...]

Bookmark and Share

Joslin Everywhere – John Brooks, Joslin Diabetes Center CEO

John Brooks sets the stage for Diabetes Innovation at last year’s conference, noting that technology can serve as a platform for partnerships and as a mechanism for enhancing community-based solutions for all people affected by diabetes, enabling collaborative care and putting patients first … Joslin Everywhere.

John Brooks, Joslin Diabetes CEO, at Joslin Innovation 2012

Diabetes Innovation 2013

Bookmark and Share

Diabetes Innovation 2013

Registration is NOW OPEN!

Catch the buzz, watch exclusive interviews and select presentations from 

Diabetes Innovation 2012!

Mission

The diabetes epidemic demands a powerful response from leaders in the diabetes community, nationally and globally. By bringing together the best minds across payers, providers, industry, government, research, prevention and treatment, Diabetes Innovation 2013 will act as a powerful marketplace of ideas, partnerships and collaboration to provoke thought, innovation and action that address the cost, productivity and quality of life impact of diabetes on our society.

Diabetes Innovation 2013 will provide a powerful foundation for sustained focus and excitement for advancement in all facets of diabetes prevention, treatment and payment reforms – from social media and gaming to translational research breakthroughs to mobile patient technologies and everything in between.

Diabetes Innovation 2013 and Joslin Diabetes Center issue a challenge to key leaders to be the catalyst for new partnerships, practical and affordable solutions, and hope in our common goal of a future without diabetes, its complications and comorbidities—and with billions of dollars in savings.

 

Bookmark and Share